Martin H Thornhill1,2, Simon Jones3,4, Bernard Prendergast5, Larry M Baddour6, John B Chambers5, Peter B Lockhart2, Mark J Dayer7. 1. Unit of Oral and Maxillofacial Medicine, Pathology and Surgery, University of Sheffield School of Clinical Dentistry, Claremont Crescent, Sheffield S10 2TA, UK. 2. Department of Oral Medicine, Carolinas Medical Center, 1000 Blythe Boulevard, Charlotte, NC 28203, USA. 3. Department of Population Health, NYU School of Medicine, NYU Translational Research Building, 227 East 30th Street, New York, NY 10016, USA. 4. Department of Clinical and Experimental Medicine, University of Surrey, 388 Stag Hill, Guildford GU2 7XH, UK. 5. Department of Cardiology, St Thomas' Hospital, Westminster bridge Road, London SE1 7EH, UK. 6. Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. 7. Department of Cardiology, Taunton and Somerset NHS Trust, Musgrove Park, Taunton, Somerset TA1 5DA, UK.
Abstract
Aims: There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. Methods and results: English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quantify subsequent IE admissions. The 5-year risk of IE or dying during an IE admission was calculated for each condition and compared with the entire English population as a control. Infective endocarditis incidence in the English population was 36.2/million/year. In comparison, patients with a previous history of IE had the highest risk of recurrence or dying during an IE admission [odds ratio (OR) 266 and 215, respectively]. These risks were also high in patients with prosthetic valves (OR 70 and 62) and previous valve repair (OR 77 and 60). Patients with congenital valve anomalies (currently considered 'moderate risk') had similar levels of risk (OR 66 and 57) and risks in other 'moderate-risk' conditions were not much lower. Congenital heart conditions (CHCs) repaired with prosthetic material (currently considered 'high risk' for 6 months following surgery) had lower risk than all 'moderate-risk' conditions-even in the first 6 months. Infective endocarditis risk was also significant in patients with cardiovascular implantable electronic devices. Conclusion: These data confirm the high IE risk of patients with a history of previous IE, valve replacement, or repair. However, IE risk in some 'moderate-risk' patients was similar to that of several 'high-risk' conditions and higher than repaired CHC. Guidelines for the risk stratification of conditions predisposing to IE may require re-evaluation.
Aims: There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. Methods and results: English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quantify subsequent IE admissions. The 5-year risk of IE or dying during an IE admission was calculated for each condition and compared with the entire English population as a control. Infective endocarditis incidence in the English population was 36.2/million/year. In comparison, patients with a previous history of IE had the highest risk of recurrence or dying during an IE admission [odds ratio (OR) 266 and 215, respectively]. These risks were also high in patients with prosthetic valves (OR 70 and 62) and previous valve repair (OR 77 and 60). Patients with congenital valve anomalies (currently considered 'moderate risk') had similar levels of risk (OR 66 and 57) and risks in other 'moderate-risk' conditions were not much lower. Congenital heart conditions (CHCs) repaired with prosthetic material (currently considered 'high risk' for 6 months following surgery) had lower risk than all 'moderate-risk' conditions-even in the first 6 months. Infective endocarditis risk was also significant in patients with cardiovascular implantable electronic devices. Conclusion: These data confirm the high IE risk of patients with a history of previous IE, valve replacement, or repair. However, IE risk in some 'moderate-risk' patients was similar to that of several 'high-risk' conditions and higher than repaired CHC. Guidelines for the risk stratification of conditions predisposing to IE may require re-evaluation.
Authors: M H Thornhill; J B Chambers; B D Prendergast; M Dayer; T J Cahill; P B Lockhart; L M Baddour Journal: Br Dent J Date: 2018-10-12 Impact factor: 1.626
Authors: Judith Bergadà-Pijuan; Michelle Frank; Sara Boroumand; Frédérique Hovaguimian; Carlos A Mestres; Robert Bauernschmitt; Thierry Carrel; Bernd Stadlinger; Frank Ruschitzka; Annelies S Zinkernagel; Roger D Kouyos; Barbara Hasse Journal: Infection Date: 2022-08-16 Impact factor: 7.455
Authors: Martin H Thornhill; Annabel Crum; Saleema Rex; Richard Campbell; Tony Stone; Mike Bradburn; Veronica Fibisan; Mark J Dayer; Bernard D Prendergast; Peter B Lockhart; Larry M Baddour; Jon Nicholl Journal: Health Technol Assess Date: 2022-05 Impact factor: 4.106
Authors: Larry M Baddour; Aylin Shafiyi; Brian D Lahr; Nandan S Anavekar; James M Steckelberg; Walter R Wilson; M Rizwan Sohail; Daniel C DeSimone Journal: Mayo Clin Proc Date: 2021-03-05 Impact factor: 11.104